Search Results
Baxter and COSMED Announce U.S. FDA 510(k) Clearance of Q-NRG+ Indirect Calorimetry Device
Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, today announced the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+, a metabolic monitoring device utilizing indirect calorimetry (IC) technology. IC is considered the "gold standard"1 to accurately measure a patient’s calorie needs, or resting energy expenditure (REE).
Baxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and Canada
Baxter International Inc. (NYSE:BAX), a leading global medical products company, and Spectral Medical Inc. (TSX:EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced a distribution agreement for TORAYMYXIN™ PMX-20R (PMX), a hemoperfusion filter, and the Endotoxin Activity Assay™ (EAA), an on-market companion diagnostic tool that aids in the risk assessment of ICU patients for progression to severe sepsis.
Baxter Aids Relief Efforts in Australia Bushfire and Puerto Rico Earthquake Disasters
2020 has brought devastation to Australia and Puerto Rico. The Baxter team is responding in real-time.
Baxter to Present at the 9th Annual SVB Leerink Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 9th Annual SVB Leerink Global Healthcare Conference in New York, N.Y. on Wednesday, February 26, 2020. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 9:30 a.m. Eastern Time.
Baxter Supporting Puerto Rico Recovery, Product Supply Continuity
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today issued this statement: Over the last several days, the people of Puerto Rico have experienced multiple earthquakes and aftershock effects, disrupting the power supply, displacing residents and complicating basic needs. Our hearts are with the people of Puerto Rico, and we are grateful that our employees are all safe and accounted for.
Baxter Announces Preliminary Net Sales for the Fourth-Quarter and Full-Year 2019 and Announces Preliminary Full-Year 2020 Guidance
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced preliminary net sales for the quarter and full year ended December 31, 2019, and preliminary full-year 2020 guidance for select financial metrics.
In Memoriam: Bob Parkinson
Robert L. Parkinson, Jr., who served as Chairman and CEO of Baxter International from 2004 through 2015, passed away on December 19.
Baxter to Present at the 38th Annual J.P. Morgan Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 13, 2020 at 10:00 a.m. Pacific Time.
Making an Impact Outside of Work
For Chris, volunteering for a cause Baxter also supports is motivating.